Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fuji
Federal Trade Commission
Accenture
Deloitte
Queensland Health
Farmers Insurance
Daiichi Sankyo
Boehringer Ingelheim
Harvard Business School

Generated: October 18, 2017

DrugPatentWatch Database Preview

Delcor Asset Corp Company Profile

« Back to Dashboard

What is the competitive landscape for DELCOR ASSET CORP, and what generic and branded alternatives to DELCOR ASSET CORP drugs are available?

DELCOR ASSET CORP has seventeen approved drugs.



Summary for Applicant: Delcor Asset Corp

US Patents:0
Tradenames:7
Ingredients:6
NDAs:17
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp
KENALOG
triamcinolone acetonide
CREAM;TOPICAL083943-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
PHENERGAN
promethazine hydrochloride
TABLET;ORAL007935-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
TABLET;ORAL060574-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOLOG-II
nystatin; triamcinolone acetonide
CREAM;TOPICAL060576-002May 1, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL011602-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
POWDER;TOPICAL060578-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
OINTMENT;TOPICAL060571-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL084343-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Delcor Asset Corp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Delcor Asset Corp
KENALOG-H
triamcinolone acetonide
CREAM;TOPICAL086240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Deloitte
Medtronic
Fish and Richardson
UBS
Novartis
Queensland Health
Citi
McKinsey
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot